Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery

NCT06201819 · Completed

Last updated 2026-05-28

This clinical trial is testing whether the medication liraglutide helps people who are preparing for weight-loss surgery lose weight before their procedure.

Status Completed The study has finished.

Phase Phase 4 Monitors a drug already on the market.

Type Interventional (clinical trial)

Design open-label (no blinding) treatment study

Participants 37 people

Who can join Ages 18+ · all sexes

Timeline Started 2022-12 · est. completion 2023-05

Where 1 site · Mexico

What this study is testing ClinicalTrials.gov NCT06201819 ↗

Description as written by the study sponsor.

Severe obesity is associated with considerable reduction of wellbeing and life expectancy. People living with severe obesity tend to die 8 to 10 years earlier. Preoperative management of patients living with severe obesity can be challenging and proper weight-loss may help obtain better outcomes and less morbidity. The effectiveness of GLP-1 analogue Liraglutide in preoperative weight-loss was evaluated in the study.

Treatments tested

Liraglutide injection Drug

Liraglutide (GLP-1 analog) injection during 3 months

Main thing measured	Preoperative weight changes
Sponsor	Hospital Civil Juan I. Menchaca
Conditions studied	Weight Loss, Bariatric Surgery Candidate, Obesity, Morbid
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT06201819 ↗